Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 13h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SEPTISOL is a topical solution containing hexachlorophene, a broad-spectrum antimicrobial agent used for surgical site preparation and skin antisepsis. The drug works by disrupting bacterial cell membranes and inhibiting protein synthesis. It is indicated for preoperative skin antisepsis in surgical settings.
Pre-Launch
Pre-launch stage indicates early-stage commercial team building with focus on surgical market entry and hospital relationships.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
R-Pharm US is hiring 4 roles related to this product
Worked on SEPTISOL at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.